The Pen Injector is an important addition to Phillips-Medisize’s expanding Product and Platform portfolio, empowering Biopharma companies to accelerate the rollout of novel and generic drug treatments at significant economies of scale.

A disposable pen for multiple therapies
This ‘ready-to-go’ solution offers all of the advantages expected from ‘state of the art’ pen designs, while benefiting from our decades of device development and large-volume manufacturing expertise to reduce the challenges of bringing affordable drugs and drug-delivery devices to market.
Sample devices currently are available to support technical evaluation and human factors studies, with clinical devices scheduled to be available by the end of 2023.
Pen Injector Features | Details |
---|---|
The customer can customize the pen to meet requirements for therapies including: |
|
Customer specified dose size: |
|
Color: |
|
Key assumptions: |
|
Technical documentation: |
|
Convenient size
Excellent patient experience
Step 1
Remove cap
Step 2
Mount needle
Step 3
Dial up and dial down to select dose and prime
Step 4
Insert, inject, remove

We support our customers’ journey
For the U.S. Food & Drug Administration (FDA) and European Medicine Agency (EMA) submissions we deliver:
- Technical specifications for pen components are provided to support customers in development of pen and cartridge assembly lines
- Part build services available for stability studies
- Technical files are prepared that customers can reference in their drug approval applications with the FDA and EMA
- Technical files for customer-specific pen customizations can also be provided
- Our customers remain the marketing authorization holder for their drug-device combinations
Technical files can be prepared for other regions and regulatory bodies.
Get started with the Phillips-Medisize pen injector platform
Learn more about the pen injector platform capabilities and our industry research.